Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. [electronic resource]
- The Annals of thoracic surgery Mar 2007
- 993-1001 p. digital
Adrenergic beta-Antagonists--therapeutic use Aged Angiotensin II Type 1 Receptor Blockers--therapeutic use Angiotensin-Converting Enzyme Inhibitors--therapeutic use Cardiotonic Agents--therapeutic use Coronary Artery Bypass--adverse effects Female Heart Diseases--prevention & control Humans Male Middle Aged Myocardial Infarction--etiology Platelet Aggregation Inhibitors--therapeutic use Postoperative Care Proportional Hazards Models Survival Analysis Treatment Outcome